A PE-backed medical technology company in Oxford specialising in organ preservation has completed a $142m primary and ...
The oversubscribed round was led by new investor HealthQuest Capital with support from existing OrganOx investors BGF and Lauxera Capital Partners, along with additional new investors Sofina ...
Financing strengthens OrganOx to expand its leadership position in organ technologyOXFORD, United Kingdom and MADISON, N.J., Feb. 24, 2025., a leading organ medical technology company, successfully co ...
Learn more at . HealthQuest Capital is a private asset firm that provides capital to transformative healthcare companies. HealthQuest Capital focuses on commercial prospects that drive enhanced ...
OrganOx announced today that it completed a $142 million primary and secondary equity financing to accelerate growth ...
GlobalData on MSN5d
OrganOx raises $142m to accelerate growth of metra platform technologyOrganOx 's metra normothermic machine perfusion platform gained approval in Australia, Europe, Canada, and the US.
OrganOx, with its system for actively preserving viable donor tissue ahead of a transplant procedure, has raised $142 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback